Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Novavax announces pediatric expansion of pivotal PREVENT-19 trial of NVX-CoV-2373

May 4, 2021

Adrenaline release immobilizes immune cell responses

May 3, 2021

MiR-17-92 as a therapeutic target in lupus nephritis and other autoimmune diseases

April 30, 2021

Xencor initiates phase I study of XmAb-564 for autoimmune diseases

April 30, 2021

SciClone evaluates COVID-19 inactivated vaccine with Zadaxin in China

April 27, 2021

Phase III MELODY study of nirsevimab to prevent RSV infection in infants meets primary endpoint

April 26, 2021

Alladapt initiates phase I/II Harmony Study of ADP-101

April 23, 2021

Observational study confirms good tolerability and efficacy of Intratect

April 23, 2021

Bharat reports second interim analysis of phase III study of Covaxin COVID-19 vaccine candidate

April 22, 2021

Valneva begins pivotal trial of COVID-19 vaccine candidate VLA-2001

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...